The newly established accord by the World Health Organization (WHO) seeks to reinforce global readiness and response mechanisms for future pandemics. It is a direct response to the lessons learned from the Covid-19 crisis, aiming to rectify past errors. The agreement emphasizes the importance of international collaboration, securing equitable access to essential medicines, and strengthening health systems across the globe.
A pivotal aspect of the accord is the Pathogen Access and Benefit-Sharing System (PABS), which facilitates the rapid exchange of pathogen data with pharmaceutical companies. This system is crucial for accelerating the development of treatments, vaccines, and diagnostic tools in the event of future pandemics.
The agreement also includes provisions for less affluent countries. The WHO is authorized to retain up to 20% of pandemic-related products, such as vaccines and testing kits, from participating nations to ensure that these vital resources are available to poorer nations, thus promoting fair access to life-saving interventions.
One of the contentious points in the agreement was Article 11, which addresses the transfer of technology related to pandemic health products. Developing nations advocated for mandatory technology transfers, while other nations preferred a voluntary approach. Ultimately, a compromise was reached that requires mutual consent for any technology transfer.
The finalization of this agreement took over three years of negotiations, culminating in intense discussions to resolve key issues at the last minute.
This accord confronts significant global challenges such as vaccine hoarding, supply chain vulnerabilities, and the disparity in access to treatments that were glaring issues during the Covid-19 pandemic.
Importantly, the pact is legally binding for member states of the WHO, symbolizing a unified global approach towards preventing future pandemic crises.
The European Union played a critical role in the negotiations by advocating for flexible and voluntary provisions within the text while simultaneously promoting global cooperation and equitable health responses.
Notably, the United States did not participate in this agreement, having previously withdrawn from the WHO and pandemic discussions under the Trump administration.
The comprehensive 32-page agreement is scheduled to be presented for final approval at the upcoming WHO annual assembly next month, where member countries are anticipated to endorse it.
Kutos : AI Assistant!
